What is the Market's View on Xtant Medical Holdings Inc (XTNT) Stock's Price and Volume Trends Friday?

2022-09-03 06:29:59 By : Ms. Tina Wang

Overall market sentiment has been high on Xtant Medical Holdings Inc (XTNT) stock lately. XTNT receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator. Xtant Medical Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on XTNT! See Full XTNT Report What is Stock Sentiment? When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall. What's Happening With XTNT Stock Today? Xtant Medical Holdings Inc (XTNT) stock is trading at $0.56 as of 12:35 PM on Friday, Sep 2, a decline of -$0.02, or -3.12% from the previous closing price of $0.58. The stock has traded between $0.51 and $0.58 so far today. Volume today is above average. So far 119,984 shares have traded compared to average volume of 53,060 shares. More About Xtant Medical Holdings Inc Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. Click Here to get the full Stock Report for Xtant Medical Holdings Inc stock.

Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.

Thank you for signing up! You're all set to receive the Morning Update newsletter

Stock Price data may be delayed up to 15 minutes.

Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy